ArticleAdvances in experimental medicine and biology2026
Assessment of Prevalence of Dientamoeba fragilis and Its Associated Factors Compared to Those of Giardia lamblia and Blastocystis sp. Among Greek Patients with Suspicion of Intestinal Parasitosis.
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDientamoeba fragilis is a cosmopolitan but overlooked amoeba-like flagellate. It may cause gastrointestinal symptoms similar to those of irritable bowel syndrome. So far, no epidemiological analysis has been conducted in Greece.
aimThis study aimed to describe the prevalence of D. fragilis infection and its associated factors in the country over the recent decade. MATERIAL AND
methodsFaecal samples from 1361 Greek patients with possible intestinal parasitosis were tested for parasites including D. fragilis. Laboratory and demographic characteristics of patients with D. fragilis infection were compared to those of patients with Giardia lamblia- and Blastocystis sp.-infection and analysed.
resultsD. fragilis was found in 4.6% of patients with possible enteric parasitosis. It ranked third after Blastocystis sp. (8.4%). It ranked second after G. lamblia (4.9%) among pathogenic intestinal protozoa. D. fragilis-infected women had a high peak at their forties (women's parenting age), while a lesser peak was found in D. fragilis-infected men in their late forties (men's parenting age). D. fragilis was more likely than G. lamblia [PR = 4.70(1.68-13.14)] and Blastocystis sp. [PR = 2.2(1.07-4.90)] to be acquired in rural areas, in which young males (<40 years) were more likely than females to become infected with D. fragilis [MH- PR = 5.76(1.70-19.54)].
conclusionsD. fragilis was identified at a low rate among Greek patients with possible intestinal parasitosis. Primary care physicians in Greece should be aware of the possibility of D. fragilis infection in people in their parenting age and in young men living in rural areas, when presented with non-specific gastrointestinal symptoms that cannot be explained by other enteropathogens and request further laboratory testing.
Indexed as
Identifiers
41479082What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.